Korro Bio Inc (KRRO)
50.13
-4.88
(-8.87%)
USD |
NASDAQ |
Nov 14, 16:00
49.37
-0.76
(-1.52%)
After-Hours: 20:00
Korro Bio Enterprise Value: 354.09M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 354.09M |
| November 12, 2024 | 448.29M |
| November 11, 2024 | 526.03M |
| November 08, 2024 | 497.20M |
| November 07, 2024 | 485.11M |
| November 06, 2024 | 462.14M |
| November 05, 2024 | 453.78M |
| November 04, 2024 | 401.70M |
| November 01, 2024 | 383.38M |
| October 31, 2024 | 377.25M |
| October 30, 2024 | 408.40M |
| October 29, 2024 | 430.53M |
| October 28, 2024 | 436.29M |
| October 25, 2024 | 476.28M |
| October 24, 2024 | 476.09M |
| October 23, 2024 | 472.93M |
| October 22, 2024 | 493.67M |
| October 21, 2024 | 547.97M |
| October 18, 2024 | 586.84M |
| October 17, 2024 | 586.56M |
| October 16, 2024 | 558.57M |
| October 15, 2024 | 212.29M |
| October 14, 2024 | 207.54M |
| October 11, 2024 | 202.15M |
| October 10, 2024 | 182.44M |
| Date | Value |
|---|---|
| October 09, 2024 | 173.88M |
| October 08, 2024 | 168.12M |
| October 07, 2024 | 176.02M |
| October 04, 2024 | 154.91M |
| October 03, 2024 | 133.62M |
| October 02, 2024 | 149.24M |
| October 01, 2024 | 149.43M |
| September 30, 2024 | 153.33M |
| September 27, 2024 | 163.47M |
| September 26, 2024 | 165.70M |
| September 25, 2024 | 162.91M |
| September 24, 2024 | 168.30M |
| September 23, 2024 | 164.96M |
| September 20, 2024 | 180.39M |
| September 19, 2024 | 200.57M |
| September 18, 2024 | 184.11M |
| September 17, 2024 | 189.13M |
| September 16, 2024 | 222.52M |
| September 13, 2024 | 227.82M |
| September 12, 2024 | 218.61M |
| September 11, 2024 | 228.19M |
| September 10, 2024 | 203.73M |
| September 09, 2024 | 200.38M |
| September 06, 2024 | 221.96M |
| September 05, 2024 | 239.90M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
77.74M
Minimum
Nov 06 2023
675.85M
Maximum
Mar 28 2024
328.74M
Average
330.86M
Median
Enterprise Value Benchmarks
| Marker Therapeutics Inc | 24.68M |
| Pliant Therapeutics Inc | 463.58M |
| CEL-SCI Corp | 38.36M |
| AIM ImmunoTech Inc | 7.900M |
| IGC Pharma Inc | 26.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.83M |
| Total Expenses (Quarterly) | 24.12M |
| EPS Diluted (Quarterly) | -2.43 |
| Earnings Yield | -19.00% |